Literature DB >> 26123802

Role of CD4+ Foxp3+ Regulatory T Cells in Protection Induced by a Live Attenuated, Replicating Type I Vaccine Strain of Toxoplasma gondii.

Haroon Akbar1, Isabelle Dimier-Poisson1, Nathalie Moiré2.   

Abstract

Vaccination with the live attenuated Toxoplasma gondii Mic1.3KO strain induced long-lasting immunity against challenge with Toxoplasma gondii type I and type II strains. The involvement of regulatory T cells (Tregs) in the protection mechanism was investigated. Intraperitoneal injection of Mic1.3KO induced a weak and transient influx of CD4(+) Foxp3(+) T regulatory cells followed by recruitment/expansion of CD4(+) Foxp3(-) CD25(+) effector cells and control of the parasite at the site of infection. The local and systemic cytokine responses associated with this recruitment of Tregs were of the TH1/Treg-like type. In contrast, injection of RH, the wild-type strain from which the vaccinal strain is derived, induced a low CD4(+) Foxp3(+) cell influx and uncontrolled multiplication of the parasites at this local site, followed by death of the mice. The associated local and systemic cytokine responses were of the TH1/TH17-like type. In addition, in vivo Treg induction in RH-infected mice with interleukin-2 (IL-2)/anti-IL-2 complexes induced control of the parasite and a TH1/Treg cytokine response similar to the response after Mic1.3KO vaccination. These results suggest that Tregs may contribute to the protective response after vaccination with Mic1.3KO.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26123802      PMCID: PMC4534668          DOI: 10.1128/IAI.00217-15

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

Review 1.  Vaccines against Toxoplasma gondii: challenges and opportunities.

Authors:  Erik Jongert; Craig W Roberts; Nicola Gargano; Elisabeth Förster-Waldl; Elisabeth Förster-Wald; Eskild Petersen
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-03       Impact factor: 2.743

2.  Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii.

Authors:  Kimberly A Jordan; Emma H Wilson; Elia D Tait; Barbara A Fox; David S Roos; David J Bzik; Florence Dzierszinski; Christopher A Hunter
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

Review 3.  Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease.

Authors:  Reiko M Onishi; Sarah L Gaffen
Journal:  Immunology       Date:  2010-03       Impact factor: 7.397

4.  Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection.

Authors:  Guillaume Oldenhove; Nicolas Bouladoux; Elizabeth A Wohlfert; Jason A Hall; David Chou; Liliane Dos Santos; Shaun O'Brien; Rebecca Blank; Erika Lamb; Sundar Natarajan; Robin Kastenmayer; Christopher Hunter; Michael E Grigg; Yasmine Belkaid
Journal:  Immunity       Date:  2009-11-05       Impact factor: 31.745

5.  Mic1-3KO tachyzoite a live attenuated vaccine candidate against toxoplasmosis derived from a type I strain shows features of type II strain.

Authors:  Nathalie Moiré; Sarah Dion; Maryse Lebrun; Jean-François Dubremetz; Isabell Dimier-Poisson
Journal:  Exp Parasitol       Date:  2009-06-07       Impact factor: 2.011

6.  Long-term immunity to lethal acute or chronic type II Toxoplasma gondii infection is effectively induced in genetically susceptible C57BL/6 mice by immunization with an attenuated type I vaccine strain.

Authors:  Jason P Gigley; Barbara A Fox; David J Bzik
Journal:  Infect Immun       Date:  2009-09-21       Impact factor: 3.441

7.  Synergistic role of micronemal proteins in Toxoplasma gondii virulence.

Authors:  Odile Cérède; Jean François Dubremetz; Martine Soête; Didier Deslée; Henri Vial; Daniel Bout; Maryse Lebrun
Journal:  J Exp Med       Date:  2005-01-31       Impact factor: 14.307

8.  Reduction of Foxp3+ cells by depletion with the PC61 mAb induces mortality in resistant BALB/c mice infected with Toxoplasma gondii.

Authors:  Eda Patricia Tenorio; Jonadab Efraín Olguín; Jacquelina Fernández; Pablo Vieyra; Rafael Saavedra
Journal:  J Biomed Biotechnol       Date:  2009-12-13

9.  In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression.

Authors:  Kylie E Webster; Stacey Walters; Rachel E Kohler; Tomas Mrkvan; Onur Boyman; Charles D Surh; Shane T Grey; Jonathan Sprent
Journal:  J Exp Med       Date:  2009-03-30       Impact factor: 14.307

10.  Tunable chemokine production by antigen presenting dendritic cells in response to changes in regulatory T cell frequency in mouse reactive lymph nodes.

Authors:  Valentina Dal Secco; Cristiana Soldani; Claire Debrat; François Asperti-Boursin; Emmanuel Donnadieu; Antonella Viola; Adelaida Sarukhan
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

View more
  5 in total

Review 1.  Is Toxoplasma gondii type related to clinical outcome in human congenital infection? Systematic and critical review.

Authors:  C P Rico-Torres; J A Vargas-Villavicencio; D Correa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-04       Impact factor: 3.267

2.  Immunization with Toxoplasma gondii GRA17 Deletion Mutant Induces Partial Protection and Survival in Challenged Mice.

Authors:  Jin-Lei Wang; Hany M Elsheikha; Wei-Ning Zhu; Kai Chen; Ting-Ting Li; Dong-Mei Yue; Xiao-Xuan Zhang; Si-Yang Huang; Xing-Quan Zhu
Journal:  Front Immunol       Date:  2017-06-29       Impact factor: 7.561

Review 3.  Immune response against toxoplasmosis-some recent updates RH: Toxoplasma gondii immune response.

Authors:  Madiha Sana; Muhammad Rashid; Imran Rashid; Haroon Akbar; Jorge E Gomez-Marin; Isabelle Dimier-Poisson
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

4.  Intraperitoneal Inoculation: An Atypical Route of Trichinella spiralis Infection.

Authors:  Peng Jiang; Zi Fang Zhang; Zhong Quan Wang; Ruo Dan Liu; Xi Zhang; Ge Ge Sun; Xin Qi; Li Wang; Jing Cui
Journal:  Iran J Parasitol       Date:  2017 Jan-Mar       Impact factor: 1.012

5.  Treatment of mice with S4B6 IL-2 complex prevents lethal toxoplasmosis via IL-12- and IL-18-dependent interferon-gamma production by non-CD4 immune cells.

Authors:  Andreas Kupz; Saparna Pai; Paul R Giacomin; Jennifer A Whan; Robert A Walker; Pierre-Mehdi Hammoudi; Nicholas C Smith; Catherine M Miller
Journal:  Sci Rep       Date:  2020-08-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.